by Impulse Dynamics | Feb 16, 2021 | News and Events, Press Releases
Impulse Dynamics Receives Medical Device Approval for European Union to Safely Administer MRI Scans for Heart Failure Patients with Implanted Optimizer Smart Devices MARLTON, N.J., February 16, 2021 — Impulse Dynamics, an international medical device company dedicated...
by Impulse Dynamics | Jan 20, 2021 | News and Events, Press Releases
FDA Clears Potential Hurdle for Many Heart Failure Patients MARLTON, N.J., January 20, 2021 — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF), today announced the U.S. Food and Drug Administration (FDA) has approved the...
by Impulse Dynamics | Jan 12, 2021 | News and Events, Press Releases
Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J., January 12, 2021 — Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with...
by Impulse Dynamics | Jan 5, 2021 | Press Releases
Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J. – January 05, 2021 – Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the first...
by Impulse Dynamics | Apr 14, 2020 | Press Releases
Availability of the two-lead device represents a significant advancement in the development of cardiac contractility modulation therapy for patients with heart failure MT. LAUREL, N.J.– April 14, 2020 – Impulse Dynamics, a medical device company dedicated to improving...
by Impulse Dynamics | Mar 17, 2020 | Press Releases
Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy MOUNT LAUREL, N.J. – March 17, 2020 Impulse Dynamics, Inc., a company dedicated to improving the lives of people with heart failure, today announced the...
